These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17765962)

  • 1. Vascular outcome in type 2 diabetes: an ADVANCE?
    Kaplan NM
    Lancet; 2007 Sep; 370(9590):804-5. PubMed ID: 17765962
    [No Abstract]   [Full Text] [Related]  

  • 2. [Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information].
    Nilsson PM
    Lakartidningen; 2007 Oct 17-23; 104(42):3028-9. PubMed ID: 17985709
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertension arm of ADVANCE defines extent of renal protection using perindopril/indapamide in type 2 diabetics.
    Cardiovasc J Afr; 2008; 19(4):226. PubMed ID: 18776973
    [No Abstract]   [Full Text] [Related]  

  • 4. The ADVANCE trial.
    Dunstan E
    Lancet; 2008 Jan; 371(9606):25-6; author reply 26. PubMed ID: 18177766
    [No Abstract]   [Full Text] [Related]  

  • 5. [ADVANCE: a morbidity mortality study of diabetes and hypertension].
    Heim A; Feihl F; Waeber B
    Rev Med Suisse; 2008 Jan; 4(139):28, 30, 32-3. PubMed ID: 18251212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Type 2 diabetes: blood pressure lowering to 135/75 mmHg reduces mortality].
    Einecke D
    MMW Fortschr Med; 2007 Sep; 149(38):18. PubMed ID: 18018407
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
    Patel A; ; MacMahon S; Chalmers J; Neal B; Woodward M; Billot L; Harrap S; Poulter N; Marre M; Cooper M; Glasziou P; Grobbee DE; Hamet P; Heller S; Liu LS; Mancia G; Mogensen CE; Pan CY; Rodgers A; Williams B
    Lancet; 2007 Sep; 370(9590):829-40. PubMed ID: 17765963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ADVANCE study: objectives, design and current status].
    Chalmers J
    Drugs; 2003; 63 Spec No 1():39-44. PubMed ID: 12708881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lowering of blood pressure after stroke.
    D'Ambrosio M
    Lancet; 2001 Dec; 358(9297):1993-4; author reply 1994-5. PubMed ID: 11747945
    [No Abstract]   [Full Text] [Related]  

  • 10. The lowering of blood pressure after stroke.
    Fournier A; Mazouz H; Choukroun G; Andrejak M; Godefroy O
    Lancet; 2001 Dec; 358(9297):1995-6. PubMed ID: 11747948
    [No Abstract]   [Full Text] [Related]  

  • 11. Vascular and renal benefits are additive using intensive blood pressure control and incremental glucose control in type 2 diabetic patients.
    Cardiovasc J Afr; 2008; 19(5):284-6. PubMed ID: 18997995
    [No Abstract]   [Full Text] [Related]  

  • 12. The lowering of blood pressure after stroke.
    Upton MN
    Lancet; 2001 Dec; 358(9297):1993; author reply 1994-5. PubMed ID: 11747943
    [No Abstract]   [Full Text] [Related]  

  • 13. What can be learned from the experience with the fixed low-dose combination of perindopril/indapamide in the treatment of hypertension?
    Waeber B
    Expert Opin Pharmacother; 2005 Oct; 6(13):2291-9. PubMed ID: 16218889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lowering of blood pressure after stroke.
    Cates C
    Lancet; 2001 Dec; 358(9297):1993; author reply 1994-5. PubMed ID: 11747944
    [No Abstract]   [Full Text] [Related]  

  • 15. The lowering of blood pressure after stroke.
    Cruickshank J
    Lancet; 2001 Dec; 358(9297):1994; author reply 1994-5. PubMed ID: 11747946
    [No Abstract]   [Full Text] [Related]  

  • 16. New Premier study suggest Preterax as a first-line antihypertensive.
    Cardiovasc J S Afr; 2004; 15(1):40-1. PubMed ID: 15095752
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of blood pressure control with perindopril/indapamide on the microcirculation in hypertensive patients.
    Debbabi H; Bonnin P; Levy BI
    Am J Hypertens; 2010 Oct; 23(10):1136-43. PubMed ID: 20508624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats.
    You D; Cochain C; Loinard C; Vilar J; Mees B; Duriez M; Lévy BI; Silvestre JS
    J Pharmacol Exp Ther; 2008 Jun; 325(3):766-73. PubMed ID: 18309090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiorenal continuum. Nephro- and cardioprotection with perindopril/indapamide therapy].
    Bischoff A
    MMW Fortschr Med; 2013 Aug; 155(14):70-1. PubMed ID: 24006602
    [No Abstract]   [Full Text] [Related]  

  • 20. [Type 2 diabetes. Routine ACE inhibitors?].
    Hönl SB
    Med Monatsschr Pharm; 2008 Apr; 31(4):149-50. PubMed ID: 18497249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.